TNK2 as a key drug target for the treatment of metastatic colorectal cancer
Authors:
- 1 November 2018
- journal article
- research article
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 119, 48-52
Abstract
No abstract availableKeywords
Funding Information
- National Key Basic Research Program of China (2015CB554002)
- NSFC-Guangdong Joint Fund (U1201226)
- National Natural Science Foundation of China (81472313, 81773101)
This publication has 23 references indexed in Scilit:
- Ack1-mediated Androgen Receptor Phosphorylation Modulates Radiation Resistance in Castration-resistant Prostate CancerJournal of Biological Chemistry, 2012
- Ack1 Tyrosine Kinase Activation Correlates with Pancreatic Cancer ProgressionThe American Journal of Pathology, 2012
- DRAR-CPI: a server for identifying drug repositioning potential and adverse drug reactions via the chemical–protein interactomeNucleic Acids Research, 2011
- Cancer-associated Mutations Activate the Nonreceptor Tyrosine Kinase Ack1Journal of Biological Chemistry, 2010
- Somatic mutation in the ACK1 ubiquitin association domain enhances oncogenic signaling through EGFR regulation in renal cancer derived cellsMolecular Oncology, 2010
- Ack1 Mediated AKT/PKB Tyrosine 176 Phosphorylation Regulates Its ActivationPLOS ONE, 2010
- PubChem: a public information system for analyzing bioactivities of small moleculesNucleic Acids Research, 2009
- TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cellsBreast Cancer Research, 2008
- Activated Cdc42-associated kinase Ack1 promotes prostate cancer progression via androgen receptor tyrosine phosphorylationProceedings of the National Academy of Sciences, 2007
- NCBI GEO: mining tens of millions of expression profiles--database and tools updateNucleic Acids Research, 2006